Quest raises profit forecast as COVID-19 tests demand to jump
By Mrinalika Roy (Reuters) - Quest Diagnostics Inc raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021. Rival Abbott Laboratories on Wednesday also projected demand for COVID-19 tests to rise next year, even if a vaccine is developed, and lifted its 2020 profit forecast.
COVID-19 tests demand to jump" src="https://images.firstpost.com/wp-content/themes/firstpost/images/220x220_Watermark.jpg" alt="Quest raises profit forecast as COVID19 tests demand to jump" width="300" height="225" />
By Mrinalika Roy
(Reuters) - Quest Diagnostics Inc raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021.
Rival Abbott Laboratories on Wednesday also projected demand for COVID-19 tests to rise next year, even if a vaccine is developed, and lifted its 2020 profit forecast.
Quest said it performed 93,000 molecular tests and 11,000 serology tests per day for COVID-19 in the quarter, with an average turnaround time of less than two days.
"We are increasing capacity and that should get us eventually coming out of this year at 250,000 ( COVID-19 tests) per day," Chief Executive Officer Stephen Rusckowski said on a call with analysts. The company currently has the capacity to perform 200,000 tests per day.
Quest is reviewing the new reimbursement policy for COVID-19 molecular testing from the Centers for Medicare & Medicaid Services.
The agency earlier this month said Medicare will pay $100 only to laboratories that complete high throughput COVID-19 diagnostic tests within two calendar days of the specimen being collected, starting Jan. 1.
"We need to understand exactly when the clock starts on turnaround time. We expect to be in very good shape around meeting the criteria," Chief Financial Officer Mark Guinan said.
The company expects 2020 adjusted earnings per share to be between $9 and $10, up from a prior forecast of $7.50 to $9.
Quest said there was an uptick in base testing volumes, which excludes COVID-19 testing, in the United States in the third quarter as healthcare centres began to operate at pre-pandemic levels.
The company said it would return the $138 million it had received under the federal government's CARES Act earlier in the year to help weather the health crisis.
Excluding items, Quest earned $4.31 per share, beating analysts' estimates of $3.73.
Revenue surged 42.4% to $2.79 billion.
(Reporting By Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber and Sriraj Kalluvila)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
VIENNA (Reuters) - The U.N. nuclear watchdog and the United States pressured Iran on Wednesday to finally explain the origin of uranium particles found almost two years ago at an old but undeclared site that Israel has called a "secret atomic warehouse". Israeli Prime Minister Benjamin Netanyahu drew attention to the Turqazabad site in Tehran in a speech to the United Nations in September 2018, urging the International Atomic Energy Agency to visit it
NEW DELHI (Reuters) - Sri Lankan President Gotabaya Rajapaksa said on Wednesday he had delivered on a key election promise to rebuild the island nation's intelligence network in the year since assuming office.
WARSAW (Reuters) - Polish authorities said on Wednesday a former secret service agent and a Chinese citizen who worked for a telecommunications company have been charged with spying for China. Reuters previously reported on the allegations against an employee of Huawei and a former Polish domestic intelligence operative who were being investigated by the Warsaw government for suspected espionage